<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03151291</url>
  </required_header>
  <id_info>
    <org_study_id>EMS and DS Tumor 01</org_study_id>
    <nct_id>NCT03151291</nct_id>
  </id_info>
  <brief_title>Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients</brief_title>
  <official_title>Effects of Physical Exercise in the Form of Whole-body Electromyostimulation (WB-EMS) Combined With Individualized Nutritional Therapy Using Specific Dietary Supplements on Cancer Patients Undergoing Curative or Palliative Anti-cancer Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients suffering from cancer often experience a loss of muscle mass and strength during
      disease and its therapy. Muscle wasting is the main characteristic of the so-called cancer
      cachexia syndrome and responsible for many therapy-related complications and a poorer
      prognosis of the patient. Stabilizing muscle mass should therefore be a great goal in cancer
      care. Physical exercise and nutrition are promising measures to combat cancer-related muscle
      atrophy but conventional exercise programs may not always be suitable for physical-weakened
      patients and increased catabolic processes are difficult to overcome by normal Nutrition -
      especially in advanced cancer. Therefore, the present study aims to test a combined approach
      of specific nutritional supplementation and exercise using the novel strength training method
      of Whole-Body electromyostimulation (WB-EMS). The study investigates the effect of a 12-week
      WB-EMS training combined with a dietary supplementation of β-hydroxy-β-methylbutyrate (HMB),
      L-carnitine (LC) or the omega-3-fatty acid eicosapentaenoic acid (EPA) on skeletal muscle
      mass, body composition, physical function, nutritional and inflammatory status, fatigue and
      quality of life in cancer patients undergoing oncological treatment. The results of this
      study may help to clarify the effectiveness of those combined interventions to counteract
      muscle wasting and other symptoms of cancer cachexia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skeletal muscle mass</measure>
    <time_frame>12 weeks</time_frame>
    <description>Skeletal muscle mass assessed by bioelectrical impedance analysis (in kg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical function - isometric muscle strength</measure>
    <time_frame>12 weeks</time_frame>
    <description>Isometric hand grip strength assessed by hand Dynamometer (in kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function - Endurance</measure>
    <time_frame>12 weeks</time_frame>
    <description>Six-minute-walk test (walking distance in m)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function - Lower limb strength</measure>
    <time_frame>12 weeks</time_frame>
    <description>30 second sit-to-stand test (number of sit-to-stand cycles)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported performance status</measure>
    <time_frame>12 weeks</time_frame>
    <description>ECOG performance status/Karnofsky index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported Quality of Life (QoL)</measure>
    <time_frame>12 weeks</time_frame>
    <description>EORTC QLQ - C30 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported Fatigue</measure>
    <time_frame>12 weeks</time_frame>
    <description>FACIT-Fatigue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory blood markers</measure>
    <time_frame>12 weeks</time_frame>
    <description>Blood collection and analysis of e.g. C-reactive protein (CRP), Albumin</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cancer</condition>
  <condition>Cancer Cachexia</condition>
  <condition>Weight Loss</condition>
  <condition>Muscle Loss</condition>
  <condition>Muscle Weakness</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>&quot;usual care&quot; control group receives individualized nutritional support (dietary advices: daily protein intake &gt; 1.0 g/kg bodyweight)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EMS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>physical exercise group performing a regular WB-EMS Training (two WB-EMS trainings per week; each session for 20 min)
+ individualized nutritional support (dietary advices: daily protein intake &gt; 1.0 g/kg bodyweight)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HMB supplemented group receives individualized nutritional support (dietary advices: daily protein intake &gt; 1.0 g/kg bodyweight) + specific dietary supplementation with HMB (3 g/d)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB+EMS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HMB supplemented physical exercise group performing a regular WB-EMS Training (two WB-EMS trainings per week; each session for 20 min)
+ individualized nutritional support (dietary advices: daily protein intake &gt; 1.0 g/kg bodyweight) + specific dietary supplementation with HMB (3 g/d)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LC group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LC supplemented group receives individualized nutritional support (dietary advices: daily protein intake &gt; 1.0 g/kg bodyweight) + specific dietary supplementation with LC (4 g/d)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LC+EMS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LC supplemented physical exercise group performing a regular WB-EMS Training (two WB-EMS trainings per week; each session for 20 min)
+ individualized nutritional support (dietary advices: daily protein intake &gt; 1.0 g/kg bodyweight) + specific dietary supplementation with LC (4 g/d)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EPA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EPA supplemented group receives individualized nutritional support (dietary advices: daily protein intake &gt; 1.0 g/kg bodyweight) + specific dietary supplementation with EPA (2.2 g/d)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EPA+EMS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EPA supplemented physical exercise group performing a regular WB-EMS Training (two WB-EMS trainings per week; each session for 20 min)
+ individualized nutritional support (dietary advices: daily protein intake &gt; 1.0 g/kg bodyweight) + specific dietary supplementation with EPA (2.2 g/d)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>β-hydroxy-β-methylbutyrate (HMB)</intervention_name>
    <description>daily intake of 3 g HMB</description>
    <arm_group_label>HMB group</arm_group_label>
    <arm_group_label>HMB+EMS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>L-carnitine (LC)</intervention_name>
    <description>daily intake of 4 g LC</description>
    <arm_group_label>LC group</arm_group_label>
    <arm_group_label>LC+EMS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Eicosapentaenoic acid (EPA)</intervention_name>
    <description>daily intake of 2.2 g EPA</description>
    <arm_group_label>EPA group</arm_group_label>
    <arm_group_label>EPA+EMS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whole-Body Electromyostimulation (WB-EMS)</intervention_name>
    <description>WB-EMS training is performed 2x/week for 12 weeks; Stimulation protocol: Frequency of 85 Hz, pulse duration of 0.35 ms, stimulation period of 6 sec, resting period of 4 sec; supervised by certified training instructors/physiotherapists participants perform simple exercises during the stimulation period following a video tutorial</description>
    <arm_group_label>EMS group</arm_group_label>
    <arm_group_label>HMB+EMS group</arm_group_label>
    <arm_group_label>LC+EMS group</arm_group_label>
    <arm_group_label>EPA+EMS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  malignant disease (solid or hematological cancer) e.g. head and neck cancer,
             colorectal carcinoma, small intestinal cancer, gastric cancer, oesophageal cancer,
             pancreas carcinoma, liver cell carcinoma, cholangiocarcinoma,lung cancer, breast
             cancer, cervix cancer, ovarian cancer, prostate cancer, renal cell carcinoma,
             malignant melanoma, patients with leukaemia and malignant lymphomas

          -  ECOG Performance Status ≤ 2

        Exclusion Criteria:

          -  simultaneous participation in other nutritional or exercise intervention trials

          -  acute cardiovascular events

          -  use of anabolic medications

          -  epilepsy

          -  severe neurological diseases

          -  skin lesions in the area of electrodes

          -  energy active metals in body

          -  pregnancy

          -  acute vein thrombosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yurdagül Zopf, Prof. Dr. med.</last_name>
    <phone>+49 9131 85-45218</phone>
    <email>yurdaguel.zopf@uk-erlangen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hans Joachim Herrmann, Dr. oec. troph.</last_name>
    <phone>+49 9131 85-45017</phone>
    <email>hans.herrmann@uk-erlangen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hector-Center for Nutrition, Exercise and Sports</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yurdagül Zopf, Prof. Dr. med.</last_name>
      <phone>+49 9131 85-45218</phone>
      <email>yurdaguel.zopf@k-erlangen.de</email>
    </contact>
    <contact_backup>
      <last_name>Hans Joachim Herrmann, Dr. oec. troph.</last_name>
      <phone>+49 9131 85-45017</phone>
      <email>hans.herrmann@uk-erlangen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 11, 2017</study_first_submitted>
  <study_first_submitted_qc>May 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2017</study_first_posted>
  <last_update_submitted>May 11, 2017</last_update_submitted>
  <last_update_submitted_qc>May 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cancer cachexia</keyword>
  <keyword>WB-EMS</keyword>
  <keyword>skeletal muscle mass</keyword>
  <keyword>exercise</keyword>
  <keyword>nutrition</keyword>
  <keyword>dietary supplements</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
    <mesh_term>Cachexia</mesh_term>
    <mesh_term>Wasting Syndrome</mesh_term>
    <mesh_term>Muscle Weakness</mesh_term>
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

